BioGaia AB ( ($SE:BIOG.B) ) has issued an announcement.
BioGaia AB’s Annual General Meeting approved key resolutions including a total dividend of SEK 6.90 per share and a SEK 5.0 million grant to its foundation aimed at reducing antibiotic resistance. The meeting also confirmed the re-election of board members and the implementation of a performance share program, reflecting BioGaia’s commitment to shareholder value and strategic initiatives.
More about BioGaia AB
BioGaia is a Swedish probiotic company specializing in microbiome research for over 35 years. It develops, markets, and sells probiotic products focusing on gut, immune, and oral health, distributed in over 100 markets.
Average Trading Volume: 146,995
Current Market Cap: SEK10.51B
Find detailed analytics on BIOG.B stock on TipRanks’ Stock Analysis page.